Keywords
> MYOBASE THESAURUS > HEALTH - DISORDER > medicine > medical treatment > pharmacotherapy
pharmacotherapy |
Documents disponibles dans cette catégorie (1232)
| Add the result to the basket | Make a suggestion | Refine your search
Extend search on down-posting(s)
Article
Ditters IAM ; Huidekoper HH ; Kruijshaar ME ; Rizopoulos D ; Hahn A ; Mongini TE ; Labarthe F ; Tardieu M ; Chabrol B ; Brassier A ; Parini R ; Parenti G ; van der Beek NAME ; van der Ploeg AT ; van den Hout JMP | England | 01/2022Article
Abicht A ; Müller J ; Lochmuller H | 23/12/2021Initial Posting: May 9, 2003; Last Update: December 23, 2021. The purpose of this overview is to increase the awareness of clinicians regarding congenital myasthenic syndromes (CMS) and their genetic causes and management. The following ar[...]Article
Tard C ; Salort-Campana E ; Michaud M ; Spinazzi M ; Nadaj Pakleza A ; Durr H ; Bouhour F ; Lefeuvre C ; Thomas R ; Arrassi A ; Taouagh N ; Sole G ; Laforet P | England | 20/12/2021Article
Article
Article
Article
Diaz-Manera J ; Kishnani PS ; Kushlaf H ; Ladha S ; Mozaffar T ; Straub V ; Toscano A ; van der Ploeg AT ; Berger KI ; Clemens PR ; Chien YH ; Day JW ; Illarioshkin S ; Roberts M ; Attarian S ; Borges JL ; Bouhour F ; Choi YC ; Erdem-Ozdamar S ; Goker-Alpan O ; Kostera-Pruszczyk A ; Haack KA ; Hug C ; Huynh-Ba O ; Johnson J ; Thibault N ; Zhou T ; Dimachkie MM ; Schoser B | England | 12/2021Article
Schoser B ; Roberts M ; Byrne BJ ; Sitaraman S ; Jiang H ; Laforet P ; Toscano A ; Castelli J ; Diaz-Manera J ; Goldman M ; van der Ploeg AT ; Bratkovic D ; Kuchipudi S ; Mozaffar T ; Kishnani PS | England | 12/2021Article
AFM Publication
Bichat M, Author ; Cukierman L, Author ; Marion S, Author ; Schanen-Bergot MO, Author ; Rivière H, Author ; Rivière H, Conceptor | AFM-TELETHON | Savoir & Comprendre | 11/2021Dans cette Fiche Technique Savoir & Comprendre sont répertoriés des essais cliniques, études observationnelles et registres qui concernent les maladies neuromusculaires et qui sont soit en préparation, soit en cours. Les informations sont issues[...]Article
Dornelles AD ; Junges APP ; Pereira TV ; Krug BC ; Gonçalves CBT ; Llerena JC Jr ; Kishnani PS ; de Oliveira HA Jr ; Schwartz IVD | 21/10/2021Article
Opal P | 14/10/2021Initial Posting: January 9, 2003; Last Update: October 14, 2021. Clinical characteristics. GAN-related neurodegeneration comprises a phenotypic continuum ranging from severe (sometimes called classic giant axonal neuropathy) to milder pure[...]Article
Article
Article
Article
Alfano LN ; Iammarino MA ; Reash NF ; Powers BR ; Shannon K ; Connolly AM ; Waldrop MA ; Noritz GH ; Shell R ; Tsao CY ; Flanigan KM ; Mendell JR ; Lowes LP | United States | 09/2021Article
Zhao X ; Feng Z ; Risher N ; Mollin A ; Sheedy J ; Ling KKY ; Narasimhan J ; Dakka A ; Baird JD ; Ratni H ; Lutz C ; Chen K ; Naryshkin N ; Ko CP ; Welch E ; Metzger F ; Weetall M | England | 09/08/2021Spinal muscular atrophy (SMA) is caused by the loss of the survival motor neuron 1 (SMN1) gene function. The related SMN2 gene partially compensates but produces insufficient levels of SMN protein due to alternative splicing of exon 7. Evrysdi™ [...]Article
Article
Article
Article
Lessard I ; Tard C ; Salort-Campana E ; Sacconi S ; Laforet P ; Behin A ; Bassez G ; Orlikowski D ; Merle P ; Nollet S ; Gallay L ; Berard F ; Bouhour F | AFM-TELETHON | Les cahiers de myologie | 07/2021Article
Weber F | 01/07/2021Initial Posting: July 18, 2003; Last Update: July 1, 2021. Clinical characteristics. Hyperkalemic periodic paralysis (hyperPP) is characterized by attacks of flaccid limb weakness (which may also include weakness of the muscles of the eyes[...]